Oct. 3 — The U.K. government released its eighth independent report on the nicotine e-cigarette study on Sept. 29, updating the key findings of the 2022 nicotine e-cigarette evidence update in the United Kingdom.

The report, commissioned by the U.K. Department of Health and Social Care and led by academics at King’s College London and a group of international collaborators, is the most comprehensive report to date. Its main focus is a systematic evaluation of the evidence on the health risks of nicotine e-cigarettes.

The UK is one of the most e-cigarette friendly countries, not only the first to make 95% harm reduction studies on e-cigarettes, but also perennially debunking the misconceptions and prejudices about nicotine and e-cigarettes, and also allowing hospitals to sell e-cigarettes, making it a haven for e-cigarettes.

Recently, the United Kingdom also said it will become the world’s first country to quit smoking as a medical product license e-cigarettes.

Compared to the United States watery e-cigarette regulation, the British government’s move is definitely a breath of fresh air in e-cigarette policy making, not banning flavored, not banning open, not banning disposable, but will set the nicotine content, they believe that e-cigarettes are an important initiative to effectively promote the UK into a smoke-free society in 2030.

The report looks primarily at data on human exposure to e-cigarettes, supplemented by results from animal and cellular studies. It provides the strongest evidence to date on the health risks of e-cigarettes. It also assesses the relative risk of smoking e-cigarettes compared to smoking, and the absolute risk compared to not smoking e-cigarettes or smoking.

Overall conclusions

Based on the evidence reviewed by the team, it was concluded that

e-cigarette smoking accounts for only a small proportion of the risk of smoking in the short to medium term.

e-cigarettes are not risk-free, especially for people who have never smoked

the evidence is mostly limited to short- and medium-term effects, and studies are needed to assess long-term e-cigarette smoking (beyond 12 months)

More standardized and consistent methods in future studies will improve the interpretation of the evidence.

Biomarkers of Toxic Exposure.

Biomarkers of toxicant exposure are measures of the level of potentially harmful substances in the body. The evidence reviewed suggests the presence of.

Significantly lower exposure to harmful substances from e-cigarettes compared to smoking, significantly reducing biomarker exposure associated with cancer, respiratory, and cardiovascular disease risk.

Similar or higher risk of exposure to harmful substances from e-cigarettes compared to no nicotine products.

There was no significant increase in toxic biomarkers following short-term secondhand e-cigarette exposure in non-smokers or non-smokers of e-cigarettes.

Researchers’ comments and the official UK view

“People who smoke e-cigarettes are exposed to much lower levels of carcinogens and other toxic substances than those who smoke. Helping people switch from smoking to e-cigarettes should be seen as a priority if the government is to achieve a smoke-free England by 2030.”

Dr Jeanelle DeGruchy, deputy chief medical officer in the UK, said: “Every minute in the UK, someone is admitted to hospital because of smoking. Every eight minutes, one person dies from a smoking-related death. This important study is the latest in a series of studies that carefully integrate the science of e-cigarettes to help reduce the damage caused by smoking.

D. concludes by stating.

“E-cigarettes are far less harmful than smoking, so the message is clear: If it’s a choice between smoking and e-cigarettes, choose e-cigarettes. If you have a choice between e-cigarettes and fresh air, choose fresh air.”